SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040488
Filing Date
2023-11-13
Accepted
2023-11-13 16:06:04
Documents
84
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form-10q.htm   iXBRL 10-Q 1168743
2 ex31-1.htm EX-31.1 17141
3 ex31-2.htm EX-31.2 17855
4 ex32-1.htm EX-32.1 11113
  Complete submission text file 0001493152-23-040488.txt   7193418

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE invo-20230930.xsd EX-101.SCH 68113
6 XBRL CALCULATION FILE invo-20230930_cal.xml EX-101.CAL 64506
7 XBRL DEFINITION FILE invo-20230930_def.xml EX-101.DEF 279948
8 XBRL LABEL FILE invo-20230930_lab.xml EX-101.LAB 504903
9 XBRL PRESENTATION FILE invo-20230930_pre.xml EX-101.PRE 395992
78 EXTRACTED XBRL INSTANCE DOCUMENT form-10q_htm.xml XML 1009512
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39701 | Film No.: 231398623
SIC: 3841 Surgical & Medical Instruments & Apparatus